Clinical Trials Browser

Phase 1 × Recurrence × afuresertib × Clear all

NCT02235740 2016-05-04

A Study Conducted in Subjects With Relapsed/Refractory Multiple Myeloma (MM); to Determine Dose of Afuresertib in Combination With Carfilzomib (Part 1) and to Investigate the Safety, Pharmacokinetic and Clinical Activity of the Combination Compared With Carfilzomib Alone (Part 2)

Phase 1 Terminated

Multiple Myeloma, Neoplasms, Recurrence